Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>BRCA1</i> Methylation in Circulating Free DNA: A Constitutional Matter?

JCO precision oncology·2026
Same author

Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas.

International journal of cancer·2026
Same author

Improving Survival Models in Health Care by Balancing Imbalanced Cohorts: A Novel Approach.

JCO clinical cancer informatics·2026
Same author

Triple-Negative Breast Cancer on the Rise or…? [Letter].

Breast cancer (Dove Medical Press)·2025
Same author

Constitutional <i>BRCA1</i> Epimutations: A Key for Understanding Basal-Like Breast and High-Grade Serous Ovarian Cancer.

Human mutation·2025
Same author

Germline variants in CDKN2A wild-type melanoma prone families.

Molecular oncology·2025

Related Experiment Video

Updated: May 17, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K

Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?

Per Eystein Lønning1, Oleksii Nikolaienko1,2, Stian Knappskog1,2

  • 1Department of Oncology, Haukeland University Hospital, Bergen, Norway.

JCO Precision Oncology
|April 3, 2025
PubMed
Summary
This summary is machine-generated.

Primary constitutional epimutations (PCEs) in BRCA1 are common in healthy females and linked to increased risk for ovarian and triple-negative breast cancer (TNBC). Further research on PCEs is crucial for understanding cancer risk.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.1K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Related Experiment Videos

Last Updated: May 17, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.1K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Area of Science:

  • Epigenetics
  • Cancer Genomics
  • Human Genetics

Background:

  • Constitutional epimutations are prenatal epigenetic changes in normal cells, classified as secondary (SCEs) or primary (PCEs).
  • While rare SCEs in MLH1, MSH2, and BRCA1 are linked to specific cancers, PCEs represent a distinct category.
  • Recent studies reveal high prevalence of mosaic BRCA1 PCEs in healthy individuals.

Purpose of the Study:

  • To review the association between constitutional epimutations, particularly PCEs, and cancer risk.
  • To highlight the prevalence and implications of BRCA1 PCEs.
  • To discuss challenges in PCE detection and future research directions.

Main Methods:

  • Literature review summarizing findings on constitutional epimutations and cancer risk.
  • Focus on primary constitutional epimutations (PCEs) and their detection challenges.
  • Analysis of population frequencies and cancer associations for BRCA1 and MGMT epimutations.

Main Results:

  • Low-level mosaic BRCA1 PCEs are found in 5%-10% of healthy females, predicting elevated risk for ovarian and triple-negative breast cancer (TNBC).
  • BRCA1 PCEs may account for approximately 20% of all TNBC cases.
  • Mosaic constitutional epimutations in MGMT are also frequent, but their cancer risk association is undetermined.

Conclusions:

  • Primary constitutional epimutations (PCEs), especially in BRCA1, are common and associated with significant cancer risks.
  • Improved detection and understanding of PCEs are essential for advancing cancer risk assessment and carcinogenesis research.
  • Further studies are needed to clarify the role of MGMT epimutations in cancer.